Showing results (1711-1720 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 5, 2012
Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazoleL A Devriese, M Mergui-Roelvink, J Wanders, et al.
Investigational New Drugs|May 23, 2012
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancerNilofer Azad, Arvind Dasari, John Arcaroli, et al.
Investigational New Drugs|May 23, 2012
A Phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignanciesJohn F Gerecitano, Joe J Stephenson, Nancy L Lewis, et al.
Investigational New Drugs|August 14, 2015
Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumorsAndrea Cercek, Jennifer Wheler, Peter E Murray, et al.
Investigational New Drugs|August 14, 2015
Subcellular localization of anthracyclines in cultured rat cardiomyoblasts as possible predictors of cardiotoxicityKazimierz Studzian, Krzysztof Kik, Malgorzata Lukawska, et al.
Investigational New Drugs|August 15, 2015
Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-betaLaurent-Olivier Roy, Marie-Belle Poirier, David Fortin
Investigational New Drugs|May 21, 2018
Discovering simple phenylboronic acid and benzoxaborole derivatives for experimental oncology - phase cycle-specific inducers of apoptosis in A2780 ovarian cancer cellsMateusz Psurski, Agnieszka Łupicka-Słowik, Agnieszka Adamczyk-Woźniak, et al.
Investigational New Drugs|May 21, 2017
Gankyrin as a potential therapeutic target for cancerChongchong Wang, Li Cheng
Investigational New Drugs|July 19, 2018
Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitroJürgen Weinreich, Florian Struller, Iaroslav Sautkin, et al.
Investigational New Drugs|June 30, 2018
Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real worldFelice Pasini, Carmen Barile, Donatella Caruso, et al.
Pageof 372